Accessibility Menu
Apyx Medical logo

Apyx Medical(NASDAQ) APYX

Market Cap$131.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-5%
5 Year-70%
1 Year+51%
1 Month-20%
$3.10
+2.31%
+0.07Today
After hours$3.12+$0.02 (+0.65%)
Apyx Medical last closing stock price
MetricPriceDate
Last closeUSD 3.122026-08-21
Apyx Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.97%USD 3.032026-08-14
1 month-20.2%USD 3.912026-07-22
3 month-24.46%USD 4.132026-05-22
Year to date-10.86%USD 3.502025-12-31
1 year+51.46%USD 2.062025-08-21
3 year-28.6%USD 4.372023-08-22
5 year-70.29%USD 10.502021-08-20
Since inception-4.92%USD 3.281992-05-01

Apyx Medical Financials at a Glance

Market Cap

$131.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$58.42M

Net Income (TTM)

-$8.63M

EPS (TTM)

-$0.20

P/E Ratio

-15.48

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$3.10

Volume

52,892

Open

$3.05

Previous Close

$3.12

Daily Range

$3.04 - $3.17

52-Week Range

$1.70 - $5.08

Estimated Earnings Date

Nov 5, 2026

APYX News

GettyImages-915092842

Why Apyx Medical's Stock Is Being Mauled Today

Brian FeroldiApr 2, 2019
Bear and coins heading downward

Why Apyx Medical Shares Got Slammed Today

Brian FeroldiFeb 21, 2019

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Apyx Medical

Apyx Medical Corporation is a company specialized in offering advanced energy solutions within the medical sector. Known for its innovative Helium Plasma Technology, Apyx provides minimally invasive surgical tools that enhance precision and reduce thermal damage during cosmetic and other medical procedures. This company is dedicated to expanding its presence and product portfolio globally, actively pursuing regulatory approvals and strategic partnerships to fortify its market position.

Products and Services

Helium Plasma Technology for cosmetic and medical procedures

Minimally invasive surgical tools

What Makes Apyx Medical Corporation Special

Apyx Medical Corporation stands out in the medical field due to its differentiated helium-based plasma technology. This technology offers increased precision and minimizes thermal damage compared to traditional methods. This appeals to both medical practitioners and patients who desire reduced recovery times and enhanced surgical outcomes.

Five Things You Need to Know

Apyx focuses on helium plasma technology, a key innovation in their product lineup.

The company aims to expand its product offerings and geographical reach.

It is working toward obtaining FDA and international regulatory approvals.

Research and development investments are pivotal to maintaining its technological edge.

Apyx forms partnerships to strengthen its distribution network and market access.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

205

CEO

Charles D. Goodwin, II

Website

apyxmedical.com

Headquarters

Clearwater, FL 33760-4004, US

APYX Financials

Key Financial Metrics (TTM)

Gross Margin

33.94%

Operating Margin

-6.06%

Net Income Margin

-14.78%

Return on Equity

-78.70%

Return on Capital

-11.96%

Return on Assets

-14.14%

Earnings Yield

-6.46%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$131.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

42.12M

Volume

52.89K

Avg. Volume

121.79K

Financials (TTM)

Gross Profit

$19.83M

Operating Income

-$3.54M

EBITDA

-$1.64M

Operating Cash Flow

-$10.13M

Capital Expenditure

-$920.00K

Free Cash Flow

-$11.05M

Cash & ST Invst.

$27.62M

Total Debt

$39.63M

Apyx Medical Performance Analysis

Apyx Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 44,510,000-8.3%
20232023-12-31USD 52,349,00017.6%
20242024-12-31USD 48,102,000-8.1%
20252025-12-31USD 52,844,0009.9%
Apyx Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3013.2%
Q42025-12-3148.8%
Q12026-03-31-34.8%
Q22026-06-3011.2%
Apyx Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.6752.0%
20232023-12-31USD -0.54-19.5%
20242024-12-31USD -0.6622.1%
20252025-12-31USD -0.27-58.7%
Apyx Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3047.2%
Q42025-12-3137.1%
Q12026-03-31-62.3%
Q22026-06-30-53.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$13.88M

+22.1%

Gross Profit

$8.87M

+25.2%

Gross Margin

63.89%

N/A

Market Cap

$131.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$641.11K

N/A

Employees

205

N/A

Net Income

-$3.24M

+14.2%

EBITDA

-$1.36M

+37.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$27.62M

-5.7%

Total Debt

$39.63M

+1.4%

Accounts Receivable

$13.61M

+21.0%

Inventory

$10.75M

+31.2%

Long Term Debt

$39.16M

+1.2%

Short Term Debt

$472.00K

+18.6%

Return on Assets

-14.14%

N/A

Return on Invested Capital

-6.84%

N/A

Free Cash Flow

-$3.56M

-137.4%

Operating Cash Flow

-$3.49M

-183.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VANIVivani Medical, Inc.
$1.38-2.13%
SERASera Prognostics, Inc.
$2.14+1.90%
LUCDLucid Diagnostics Inc.
$0.96+0.41%
RPIDRapid Micro Biosystems, Inc.
$1.68+0.60%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About APYX

What is the current price of Apyx Medical?

Apyx Medical is trading at $3.12 per share.

What is the 52-week range for Apyx Medical?

Over the past 52 weeks, Apyx Medical has traded between $1.70 and $5.08.

How much debt does Apyx Medical have?

As of the most recent reporting period, Apyx Medical reported total debt of $39.63M.

How much cash does Apyx Medical have on hand?

Apyx Medical reported $27.62M in cash and cash equivalents in its most recent financial results.

What is Apyx Medical’s dividend yield?

Apyx Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services